CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in…
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
